Sauer François, Riou Marianne, Charles Anne-Laure, Meyer Alain, Andres Emmanuel, Geny Bernard, Talha Samy
University of Strasbourg, Translational Medicine Federation of Strasbourg (FMTS), Faculty of Medicine, Team 3072 "Mitochondria, Oxidative Stress and Muscle Protection", 11 rue Humann, 67000 Strasbourg, France.
University Hospital of Strasbourg, Physiology and Functional Exploration Service, 1 Place de l'Hôpital, 67091 Strasbourg, France.
J Clin Med. 2022 Jan 29;11(3):741. doi: 10.3390/jcm11030741.
Heart failure (HF) is a leading cause of hospitalization in patients aged more than 65 years and is associated with high mortality rates. A better comprehension of its physiopathology is still needed, and, in addition to neurohormonal systems and sodium glucose co-transporter 2 modulations, recent studies focus on the mitochondrial respiration of peripheral blood circulating cells (PBMCs). Thus, cardiovascular metabolic risk factors and cellular switch with an increased neutrophil/lymphocytes ratio might favor the decreased PBMC mitochondrial respiration observed in relation with HF severity. PBMCs are implicated in the immune system function and mitochondrial dysfunction of PBMC, potentially induced by their passage through a damaged heart and by circulating mitoDAMPs, which can lead to a vicious circle, thus sustaining negative cardiac remodeling during HF. This new approach of HF complex pathophysiology appears to be a promising field of research, and further studies on acute and chronic HF with reduced or preserved LVEF are warranted to better understand whether circulating PBMC mitochondrial function and mitoDAMPs follow-ups in HF patients might show diagnosis, prognosis or therapeutic usefulness.
心力衰竭(HF)是65岁以上患者住院治疗的主要原因,且与高死亡率相关。目前仍需要对其病理生理学有更深入的理解,除了神经激素系统和钠葡萄糖协同转运蛋白2调节外,近期研究聚焦于外周血循环细胞(PBMCs)的线粒体呼吸。因此,心血管代谢危险因素以及中性粒细胞/淋巴细胞比率增加所导致的细胞转变,可能会促使与HF严重程度相关的PBMC线粒体呼吸降低。PBMCs参与免疫系统功能,其线粒体功能障碍可能由其通过受损心脏以及循环中的线粒体损伤相关分子模式(mitoDAMPs)所诱发,这可能导致恶性循环,从而在HF期间维持心脏负性重构。这种关于HF复杂病理生理学的新方法似乎是一个很有前景的研究领域,有必要对射血分数降低或保留的急慢性HF进行进一步研究,以更好地了解HF患者循环PBMC线粒体功能和mitoDAMPs监测是否具有诊断、预后或治疗价值。